The Impact of Coronary Artery Disease on Outcomes in Patients With Peripartum Cardiomyopathy

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 May 30

PMID 38813289

Authors

Omar Elkattawy

Jay V Phansalkar

Sherif Elkattawy

Omar Mohamed

Jahanzeb Javed

Afif Hossain

Kulsum Larry

Shriya Patel

Yash Shah

Fayez Shamoon

Affiliations

Soon will be listed here.

Abstract

Introduction The purpose of this study was to determine the prevalence of coronary artery disease (CAD) among patients admitted with peripartum cardiomyopathy (PPCM) as well as to analyze the independent association of CAD with in-hospital outcomes among PPCM patients. Methods Data were obtained from the National Inpatient Sample from January 2016 to December 2019. We assessed the independent association of CAD with outcomes in patients admitted with PPCM. Predictors of mortality in patients admitted with PPCM were also analyzed. Results There was a total of 4,730 patients with PPCM, 146 of whom had CAD (3.1%). Multivariate analysis demonstrated that CAD in patients with PPCM was independently associated with several outcomes, and, among them, ST-segment elevation myocardial infarction (STEMI) (adjusted odds ratio (aOR): 58.457, 95% CI: 5.403-632.504, p= 0.001) was positively associated with CAD. CAD was found to be protective against preeclampsia (aOR: 0.351, 95% CI: 0.126-0.979, p = 0.045). Predictors of in-hospital mortality for patients with PPCM include cardiogenic shock (aOR: 12.818, 95% CI: 7.332-22.411, p = 0.001), non-ST elevation myocardial infarction (NSTEMI) (OR: 3.429, 95% CI: 1.43-8.22, p = 0.006), chronic kidney disease (OR: 2.851, 95% CI: 1.495-5.435, p = 0.001), and atrial fibrillation (OR: 2.326, 95% CI: 1.145-4.723, p = 0.020). Conclusion In a large cohort of patients admitted with PPCM, we found the prevalence of CAD to be 3.1%. CAD was associated with several adverse outcomes, including STEMI, but protective against preeclampsia.

References

Robich M, Chu L, Oyamada S, Sodha N, Sellke F . Myocardial therapeutic angiogenesis: a review of the state of development and future obstacles. Expert Rev Cardiovasc Ther. 2011; 9(11):1469-79. PMC: 4839193. DOI: 10.1586/erc.11.148. View

Rusinaru D, Houpe D, Szymanski C, Levy F, Marechaux S, Tribouilloy C . Coronary artery disease and 10-year outcome after hospital admission for heart failure with preserved and with reduced ejection fraction. Eur J Heart Fail. 2014; 16(9):967-76. DOI: 10.1002/ejhf.142. View

Ferraro B, Shah K, Krinock M, Modi V, Pandya M, Thyagaturu H . Impact of Atrial Fibrillation on In-hospital Outcomes and Healthcare Resource Utilization of Women With Peripartum Cardiomyopathy: A Study From National Inpatient Sample. Curr Probl Cardiol. 2022; 48(1):101425. DOI: 10.1016/j.cpcardiol.2022.101425. View

Chamberlain A, Redfield M, Alonso A, Weston S, Roger V . Atrial fibrillation and mortality in heart failure: a community study. Circ Heart Fail. 2011; 4(6):740-6. PMC: 3222889. DOI: 10.1161/CIRCHEARTFAILURE.111.962688. View

Ryan D, Banerjee D, Jouhra F . Management of Heart Failure in Patients with Chronic Kidney Disease. Eur Cardiol. 2022; 17:e17. PMC: 9376857. DOI: 10.15420/ecr.2021.33. View

Arany Z, Elkayam U . Peripartum Cardiomyopathy. Circulation. 2016; 133(14):1397-409. DOI: 10.1161/CIRCULATIONAHA.115.020491. View

Bello N, Hurtado Rendon I, Arany Z . The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol. 2013; 62(18):1715-1723. PMC: 3931606. DOI: 10.1016/j.jacc.2013.08.717. View

Davis M, Arany Z, McNamara D, Goland S, Elkayam U . Peripartum Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020; 75(2):207-221. DOI: 10.1016/j.jacc.2019.11.014. View

Elkayam U, Goland S, Pieper P, Silversides C . High-Risk Cardiac Disease in Pregnancy: Part II. J Am Coll Cardiol. 2016; 68(5):502-516. DOI: 10.1016/j.jacc.2016.05.050. View

10.

White B, Mehta R, Binkley P, Leier C . Latent development of occlusive coronary atherosclerosis as a cause of decompensation of non-ischemic dilated cardiomyopathy. Cardiology. 2008; 112(1):69-73. DOI: 10.1159/000137703. View

11.

Patten I, Rana S, Shahul S, Rowe G, Jang C, Liu L . Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012; 485(7398):333-8. PMC: 3356917. DOI: 10.1038/nature11040. View

12.

Stergiopoulos K, Lima F . Peripartum cardiomyopathy-diagnosis, management, and long term implications. Trends Cardiovasc Med. 2018; 29(3):164-173. DOI: 10.1016/j.tcm.2018.07.012. View

13.

Njolstad I, Arnesen E, Lund-Larsen P . Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation. 1996; 93(3):450-6. DOI: 10.1161/01.cir.93.3.450. View

14.

Buddeke J, Bots M, van Dis I, Visseren F, Hollander M, Schellevis F . Comorbidity in patients with cardiovascular disease in primary care: a cohort study with routine healthcare data. Br J Gen Pract. 2019; 69(683):e398-e406. PMC: 6532812. DOI: 10.3399/bjgp19X702725. View

15.

Bawaskar P, Thomas N, Ismail K, Guo Y, Chhikara S, Athwal P . Nonischemic or Dual Cardiomyopathy in Patients With Coronary Artery Disease. Circulation. 2023; 149(11):807-821. PMC: 10951941. DOI: 10.1161/CIRCULATIONAHA.123.067032. View

16.

Canu M, Margerit L, Mekhdoul I, Broisat A, Riou L, Djaileb L . Prognosis of Coronary Atherosclerotic Burden in Non-Ischemic Dilated Cardiomyopathies. J Clin Med. 2021; 10(10). PMC: 8158137. DOI: 10.3390/jcm10102183. View

17.

Vasheghani-Farahani A, Kazemnejad F, Sadeghniiat-Haghighi K, Saadat S, Tavakolipoor P, Yazdani T . Obstructive sleep apnea and severity of coronary artery disease. Caspian J Intern Med. 2018; 9(3):276-282. PMC: 6121336. DOI: 10.22088/cjim.9.3.276. View

18.

McNamara D, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G . Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol. 2015; 66(8):905-14. PMC: 5645077. DOI: 10.1016/j.jacc.2015.06.1309. View

19.

Sliwa K, Hilfiker-Kleiner D, Petrie M, Mebazaa A, Pieske B, Buchmann E . Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010; 12(8):767-78. DOI: 10.1093/eurjhf/hfq120. View

20.

Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K . A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007; 128(3):589-600. DOI: 10.1016/j.cell.2006.12.036. View